These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3096 related articles for article (PubMed ID: 22488764)

  • 1. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ
    Hepatology; 2012 Jun; 55(6):2005-23. PubMed ID: 22488764
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Gastroenterology; 2012 Jun; 142(7):1592-609. PubMed ID: 22656328
    [No Abstract]   [Full Text] [Related]  

  • 3. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
    Chalasani N; Younossi Z; Lavine JE; Diehl AM; Brunt EM; Cusi K; Charlton M; Sanyal AJ; ; ;
    Am J Gastroenterol; 2012 Jun; 107(6):811-26. PubMed ID: 22641309
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease in children.
    Janczyk W; Socha P
    Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):297-300. PubMed ID: 22521558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and type 2 diabetes mellitus: the hidden epidemic.
    Ismail MH
    Am J Med Sci; 2011 Jun; 341(6):485-92. PubMed ID: 21412139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From NAFLD in clinical practice to answers from guidelines.
    Nascimbeni F; Pais R; Bellentani S; Day CP; Ratziu V; Loria P; Lonardo A
    J Hepatol; 2013 Oct; 59(4):859-71. PubMed ID: 23751754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: Drug therapy for non-alcoholic fatty liver disease.
    Comar KM; Sterling RK
    Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatty liver and its clinical management in obese adolescents].
    González Jiménez E; Schmidt Río-Valle J; Álvarez Ferre J
    Endocrinol Nutr; 2011 Jan; 58(1):32-7. PubMed ID: 21216209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brief introduction of American practice guideline for the diagnosis and management of non-alcoholic fatty liver disease].
    Ding XD; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):430-1. PubMed ID: 23230594
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
    Bugianesi E; Marzocchi R; Villanova N; Marchesini G
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1105-16. PubMed ID: 15561641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenetic treatment of non-alcoholic steatohepatitis: arguments, efficacy, safety].
    Bueverov AO; Bogomolov PO; Maevskaia MV
    Ter Arkh; 2007; 79(8):88-92. PubMed ID: 17926479
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
    Farrell GC; Chitturi S; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
    [No Abstract]   [Full Text] [Related]  

  • 13. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
    Lebovics E; Rubin J
    Diabetes Metab Res Rev; 2011 Jul; 27(5):419-24. PubMed ID: 21425426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric nonalcoholic fatty liver disease.
    Lerret SM; Skelton JA
    Gastroenterol Nurs; 2008; 31(2):115-9. PubMed ID: 18391799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fatty liver and raised gamma-GT: it can happen to abstainers, too].
    Bischoff A
    MMW Fortschr Med; 2002 Feb; 144(7):18. PubMed ID: 11887726
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of dyslipidemia in patients with complicated metabolic syndrome.
    Davidson MH
    Am J Cardiol; 2005 Aug; 96(4A):22E-25E. PubMed ID: 16098839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2013 Dec; 19(4):325-48. PubMed ID: 24459637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 155.